Micafungin (Micafungin Sodium) Patent Expiration, LOE Window & CMS Spending

Micafungin (Micafungin Sodium) by Ph Health: Off-Patent Genericized (AB Competition), 10 AB generics, $10.1M 2024 CMS Part D & Medicaid spend, and $1,000 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPh Health
FDA Application & PathwayN212156 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors10
2024 CMS Total Public Spend$10.1M
2024 Medicare Part D Spend$6.6M
2024 Medicaid Spend$3.5M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,000 intro WAC)